Investing Profile

Prem Tumkosit

VCInvestor
Managing Director at Cardiaccs AS
msdghifund.comNew York City
Photo of Prem Tumkosit, Managing Director at Cardiaccs AS

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
520 CONNECTIONS
Accenture Network
423 CONNECTIONS
Credit Suisse Network
320 CONNECTIONS
Yale School of Management Network
47 CONNECTIONS
Cardiaccs AS Network
38 CONNECTIONS
cb
Cardiaccs AS Managing Director
$100K - $5.0M
$1.5M
7
CompanyStageDateRound SizeTotal Raised
Unnatural Products
Series BMar 2026$45M
Series ADec 2023$32M
$83M
Co-investors: Vasudev Bailey (Artis Ventures (AV)), Nicholas Shekerdemian (The Venture Collective (TVC)), Ameena El-Bibany (Artis Ventures (AV))
Ash
Series AOct 2024$10M
$16M
Co-investors: Kevin Alvarez-Fung (Predictive VC), Brandon Hoffman (Sunset Ventures), Diana Melencio (XRC Ventures), David Yakobovitch (DataPower Ventures), Sreeraman M G (Fynd), Christine Tsai (500 Global)
Pragma Bio
Series AMar 2023$10M
$15M
Co-investors: Nicholas Shekerdemian (The Venture Collective (TVC)), Milad Alucozai (Entrepreneur First)
Absci
Corporate RoundFeb 2021
$70M
Co-investors: Eli Casdin (Casdin Capital, LLC)
Zapata Quantum
Series BNov 2020$38M
$59M
Co-investors: Markus Solibieda (Dussur | دسر)
Strata Oncology
Series BMay 2018$26M
$26M
Student Researcher University of Pennsylvania School of MedicinePresent
Consultant, Management Consulting - Strategy AccenturePresent
Consultant, Management Consulting - Strategy Cardiaccs ASPresent
Investment Banking Associate Credit SuissePresent
Managing Director Cardiaccs ASPresent
University of Pennsylvania BA Distinction in Biochemistry
Yale School of Management MBA Finance, Healthcare
Sign in with Google →
Sign in with Google →